RotoGro claims its Canadian patent for a gardening system is being infringed upon by RavenQuest and its CEO George Robinson.

RotoGro International (ASX:RGI) is claiming patent infringement by Canadian cannabis company RavenQuest BioMed (CSE:RQB).

On Monday (November 4), RotoGro — a subsidiary of RotoGro International — indicated that it has filed a claim in the Federal Court of Canada against RavenQuest due to patent infringement.

Court documents show the claim was filed at the end of October. According to the filed documents, RotoGro also names CL2G Consulting, Synergy Solutions Management, 1052543 BC and William George Robinson, who acts as CEO of RavenQuest.

The Australian company obtained its patent in October from the Canadian Intellectual Property Office. The patent grants RotoGro exclusive rights to its gardening system.

This dispute goes back to the end of 2017. According to RotoGro, Robinson purchased two RotoGro patented gardening systems under the CL2G name in July 2017. Later in the year, the executive attempted to negotiate a licencing deal for the intellectual property rights to the system.

RotoGro argues that despite there never being a formal licencing agreement between the two parties, or with RavenQuest, a promotional paper for the Canadian firm includes what the company describes as an unlicenced drawing identical to the one for its patent.

Adam Clode, CEO of RotoGro, said the acquired patents for the company’s gardening system in the US and Canada are vital to its business in North America and that RotoGro will defend its claim.

“As such, it is important for us to protect and defend our inventions against all individuals and businesses that look to replicate and unlawfully benefit from our patented and proprietary intellectual property,” said Clode. “We owe this duty to our shareholders, and to the company as a whole.”

According to RotoGro, the patent itself protects the following: “A stacked rotatable gardening system comprising numerous modular rotatable gardens being stacked vertically (i.e., one on top of the other) and horizontally (i.e., side by side), where each main frame is connected to the main frame of the other modular rotatable garden, forming system pods.”

On Wednesday (November 6), RavenQuest issued its own response to the claim from the Australian firm. The Canadian company indicated that the notice from RotoGro has no merit since the system RavenQuest uses was developed with its own intellectual property.

“The board of directors of Ravenquest has commenced a review of the claim, and has engaged counsel to defend its intellectual property rights and ensure that its business interests are fully protected,” the company stated.

Shares of RotoGro have been on the rise since it made its claim public to the market on Monday. However, in Wednesday’s trading session, the company fell 5.56 percent to a closing price of AU$0.17.

RavenQuest has seen a steady share price drop since Monday; on Wednesday the company opened at a price of C$0.14 and faced a slash of 9.38 percent in value. Since Monday, shares of the company have dropped 34.1 percent.

Don’t forget to follow us @INN_Australia for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

How to Access Medical Cannabis in Australia

Recreational cannabis remains out of reach in Australia, but the country legalised medical cannabis in 2016, opening up access to the cannabis market for both Australians and investors alike.

Cannabis in Australia is used to treat a myriad of conditions, from epilepsy to neuropathic pain, but federal legislation has a strict hold on the distribution of cannabis in the country.

Patients can only receive medicinal cannabis products via a specialist and then may have to wait up to a month for government approval. However, there are signs that the limits to access are slowly lessening, including the approval of over-the-counter cannabidiol (CBD) products and new breakthroughs in government-sponsored medical cannabis research.

Keep reading... Show less

Australia Mining Update: H1 2021 in Review

Click here to read the previous Australia mining update.

After an uncertain 2020 for the Australian mining industry, the resource market showed signs of a sharp recovery in the first six months of the new year.

Prices for iron ore are supporting resource exports in the country, with many ASX-listed mining companies also posting gains year-to-date.

Here the Investing News Network looks at what's happened in Australia's mining sector so far in 2021, and what could be ahead in the second half.

Keep reading... Show less

Medlab Clinical Ltd Executes Master Services Agreement with WEP Clinical Ltd

Sydney, Australia (ABN Newswire) – Medlab Clinical Ltd (ASX.MDC), an Australian biotech using delivery platforms to enhance medicines is pleased to announce the execution of a Master Services Agreement (MSA) with WEP Clinical Ltd (WEP) for the exclusive development and delivery of Named Patient Programmes relating to the unlicensed supply of its proprietary NanaBis(TM) and NanoCBD(TM) to patients in the UK and Europe.

This Master Services Agreement is the first partnership for Medlab to supply their cannabinoid medications outside of its current Australian Special Access Scheme.

Dr Sean Hall, CEO of Medlab stated, “This is a major milestone for Medlab to begin supplying NanaBis(TM) and NanoCBD(TM) on prescription for the first time to patients outside Australia.”

Keep reading... Show less

Investing in Lithium in Australia

After the country became the world’s largest lithium producer in 2018, many market participants are wondering if investing in lithium in Australia is a good option

Without a doubt, the energy revolution is here to stay, with forecasts for electric vehicle (EV) sales increasing every day. As a result, demand for lithium, a key element in the lithium-ion batteries used to power electric cars, is expected to triple by 2025 — reaching about 1 million tonnes in size.

For investors interested in getting into the space, here’s a brief overview of the basic facts to know about investing in lithium in Australia, including what stocks to keep an eye on.

Keep reading... Show less

How to Buy Bitcoin in Australia

Investors looking for decentralised assets (and potentially major gains) in a post-COVID-19 Australia are turning in droves to cryptocurrencies.

Bitcoin in particular is getting Aussies excited after its price hit record highs in March 2021, and again the next month. As a finite resource, its volatility is proving exciting for many market watchers.

For those interested in jumping into the space, the Investing News Network has put together a step-by-step guide on how to start buying bitcoin in Australia — and how to stay safe while doing so.

Keep reading... Show less

How to Access Medical Cannabis in Australia

Recreational cannabis remains out of reach in Australia, but the country legalised medical cannabis in 2016, opening up access to the cannabis market for both Australians and investors alike.

Cannabis in Australia is used to treat a myriad of conditions, from epilepsy to neuropathic pain, but federal legislation has a strict hold on the distribution of cannabis in the country.

Patients can only receive medicinal cannabis products via a specialist and then may have to wait up to a month for government approval. However, there are signs that the limits to access are slowly lessening, including the approval of over-the-counter cannabidiol (CBD) products and new breakthroughs in government-sponsored medical cannabis research.

Keep reading... Show less

Medlab Clinical Ltd Executes Master Services Agreement with WEP Clinical Ltd

Sydney, Australia (ABN Newswire) – Medlab Clinical Ltd (ASX.MDC), an Australian biotech using delivery platforms to enhance medicines is pleased to announce the execution of a Master Services Agreement (MSA) with WEP Clinical Ltd (WEP) for the exclusive development and delivery of Named Patient Programmes relating to the unlicensed supply of its proprietary NanaBis(TM) and NanoCBD(TM) to patients in the UK and Europe.

This Master Services Agreement is the first partnership for Medlab to supply their cannabinoid medications outside of its current Australian Special Access Scheme.

Dr Sean Hall, CEO of Medlab stated, “This is a major milestone for Medlab to begin supplying NanaBis(TM) and NanoCBD(TM) on prescription for the first time to patients outside Australia.”

Keep reading... Show less

When Will Australia Legalise Recreational Cannabis?

Recreational cannabis remains illegal in all Australia’s states and territories with the exception of the Australian Capital Territory (ACT). But could that change in the future?

So far there are no clear indicators as to when or if Australia could legalise recreational cannabis, but attitudes seem to be changing. Public support is growing, and there’s even some political acceptance.

Read on to learn more about when Australia may legalise recreational cannabis.

Keep reading... Show less

A State-by-State Guide to Cannabis in Australia

Australia made waves when it federally legalised medicinal cannabis in 2016, and its marijuana market has experienced significant growth since then.

A study from FreshLeaf Analytics pegs Australian medical market sales at AU$95 million in 2020, while research firm Prohibition Partners indicates that Oceania’s cannabis industry is expected to be worth US$1.55 billion by 2024; medicinal cannabis is expected to account for 40 percent of the industry.

Despite that growth, the country’s cannabis industry is still young. Recreational use is not yet in sight, and even medical access remains limited and highly regulated.

Keep reading... Show less

Australian Cannabis: Forecasts, Analysis and Expert Advice

Are you ready to start investing in Australia’s growing cannabis market?

Dive right in with our FREE Special Report, Australian Cannabis: Forecasts, Analysis and Expert Advice

Keep reading... Show less

Top News

Related News